235 related articles for article (PubMed ID: 8862506)
1. A prolactin-secreting tumor in a patient with Klinefelter's syndrome: a case report.
Pinto AC; Czepielewski MA; Gross JL; Mussio W; Lengyel AM
J Endocrinol Invest; 1996 Apr; 19(4):248-52. PubMed ID: 8862506
[TBL] [Abstract][Full Text] [Related]
2. Klinefelter's syndrome: examination of thyroid function, and the TSH and PRL responses to thyrotropin-releasing hormone prior to and after testosterone administration.
Burman KD; Dimond RC; Noel GL; Earll JM; Frantz AG; Wartofsky L
J Clin Endocrinol Metab; 1975 Dec; 41(06):1161-6. PubMed ID: 812883
[TBL] [Abstract][Full Text] [Related]
3. Graves' disease associated with Klinefelter's syndrome.
Park JS; Kim CS; Nam JY; Kim DM; Yoon SJ; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
Yonsei Med J; 2004 Apr; 45(2):341-4. PubMed ID: 15119010
[TBL] [Abstract][Full Text] [Related]
4. [Three patients with gynaecomastia].
Walraven M; Wilmink HJ; de Boer LM; Muller AF
Ned Tijdschr Geneeskd; 2004 Apr; 148(17):809-13. PubMed ID: 15141644
[TBL] [Abstract][Full Text] [Related]
5. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism.
Bojesen A; Kristensen K; Birkebaek NH; Fedder J; Mosekilde L; Bennett P; Laurberg P; Frystyk J; Flyvbjerg A; Christiansen JS; Gravholt CH
Diabetes Care; 2006 Jul; 29(7):1591-8. PubMed ID: 16801584
[TBL] [Abstract][Full Text] [Related]
6. Increased prolactin secretion and thyrotrophin response to thyrotrophin releasing hormone in Klinefelter's syndrome.
Kumanov P
Andrologia; 1995; 27(1):41-5. PubMed ID: 7755189
[TBL] [Abstract][Full Text] [Related]
7. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
Ozata M; Bulur M; Beyhan Z; Sengül A; Saglam M; Turan M; Corakci A; Ali Gundogan M
Endocr J; 1997 Oct; 44(5):719-24. PubMed ID: 9466329
[TBL] [Abstract][Full Text] [Related]
8. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
[TBL] [Abstract][Full Text] [Related]
9. Effects of gonadotropin and testosterone treatments on plasma leptin levels in male patients with idiopathic hypogonadotropic hypogonadism and Klinefelter's syndrome.
Ozata M; Ozisik G; Caglayan S; Yesilova Z; Bingöl N; Saglam M; Turan M; Beyhan Z
Horm Metab Res; 1998 May; 30(5):266-71. PubMed ID: 9660087
[TBL] [Abstract][Full Text] [Related]
10. Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition.
Bojesen A; Høst C; Gravholt CH
Mol Hum Reprod; 2010 Jun; 16(6):396-401. PubMed ID: 20231162
[TBL] [Abstract][Full Text] [Related]
11. The influence of testosterone substitution on bone mineral density in patients with Klinefelter's syndrome.
Kübler A; Schulz G; Cordes U; Beyer J; Krause U
Exp Clin Endocrinol; 1992; 100(3):129-32. PubMed ID: 1305064
[TBL] [Abstract][Full Text] [Related]
12. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
Mahler C; Verhelst J; Klaes R; Trouillas J
Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
[TBL] [Abstract][Full Text] [Related]
13. [Klinefelter's syndrome: diagnosis and treatment. Case report].
Martini R
Minerva Med; 2001 Oct; 92(5):385-92. PubMed ID: 11675582
[TBL] [Abstract][Full Text] [Related]
14. Tremor in Klinefelter's syndrome improved by testosterone administration.
Kinoshita H; Ohkubo T; Kaneko M; Satoh N; Mizutani S; Yasuda M; Machida A; Ishikawa K; Kamata T; Yakushiji F
J Neurol; 2009 Nov; 256(11):1924-5. PubMed ID: 19597693
[TBL] [Abstract][Full Text] [Related]
15. Leg ulcer in Klinefelter's syndrome.
Igawa K; Nishioka K
J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):62-4. PubMed ID: 12602973
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis, evaluation and treatment of hypogonadism in men].
Rabijewski M; Zgliczyński W
Endokrynol Pol; 2009; 60(3):222-33. PubMed ID: 19569024
[TBL] [Abstract][Full Text] [Related]
17. Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement.
Wong FH; Pun KK; Wang C
Osteoporos Int; 1993 Jan; 3(1):3-7. PubMed ID: 8422513
[TBL] [Abstract][Full Text] [Related]
18. Plasma insulin-like factor 3 (INSL3) in male patients with osteoporosis and Klinefelter's syndrome.
Hussain A; Swaminathan R; Sankaralingam A; Carroll PV; Hampson G; McGowan BM
Ital J Anat Embryol; 2013; 118(1 Suppl):34-6. PubMed ID: 24640568
[TBL] [Abstract][Full Text] [Related]
19. Testosterone therapy in Klinefelter's syndrome (a prolonged observation).
Ruvalcaba RH
Andrologia; 1989; 21(6):535-41. PubMed ID: 2619099
[TBL] [Abstract][Full Text] [Related]
20. [EEG of Klinefelter's syndrome with psychiatric disorders, and the effect of testosterone treatment].
Takei H
Seishin Shinkeigaku Zasshi; 1970 Oct; 72(10):983-1021. PubMed ID: 5531658
[No Abstract] [Full Text] [Related]
[Next] [New Search]
